Puromycin resistance gene as an effective selection marker for ciliate Tetrahymena  by Iwamoto, Masaaki et al.
Gene 534 (2014) 249–255
Contents lists available at ScienceDirect
Gene
j ourna l homepage: www.e lsev ie r .com/ locate /genePuromycin resistance gene as an effective selection marker for
ciliate Tetrahymena
Masaaki Iwamoto a, Chie Mori a, Yasushi Hiraoka a,b,c, Tokuko Haraguchi a,b,c,⁎
a Advanced ICT Research Institute Kobe, National Institute of Information and Communications Technology (NICT), Kobe 651-2492, Japan
b Graduate School of Frontier Biosciences, Osaka University, Suita 565-0871, Japan
c Graduate School of Science, Osaka University, Toyonaka 560-0043, JapanAbbreviations: bsr, blasticidin S-resistant gene; BTU2, b
mutation expressing cycloheximide sensitive; cy-s, cyclo
(2-hydroxyethyl)-1-piperazineethanesulfonic acid;HHF1,
H1 gene; IC90, 90% inhibitory concentration; mpr1-1,
methylpurine sensitive; mp-s, 6-methylpurine sensitive
neo, neomycin-resistant gene; SEH1, nucleoporin Seh1 g
transferase gene; pVGF1, plasmid vector for the expressio
tative Tetrahymena cells; 3′ UTR, three prime untranslated
⁎ Corresponding author at: Advanced ICT Research Inst
Iwaoka-cho, Nishi-ku, Kobe 651-2492, Japan. Tel.: +81 7
2249.
E-mail address: tokuko@nict.go.jp (T. Haraguchi).
0378-1119 © 2013 The Authors. Published by Elsevier B.V
http://dx.doi.org/10.1016/j.gene.2013.10.049a b s t r a c ta r t i c l e i n f oArticle history:
Accepted 23 October 2013
Available online 1 November 2013
Keywords:
Selection marker
Puromycin-N-acetyltransferase
Gene manipulation
Transformation
Ciliate
Tetrahymena thermophilaA puromycin-N-acetyltransferase gene (pac) is widely used as a selection marker for eukaryotic gene ma-
nipulation. However, it has never been utilized for molecular studies in the ciliate Tetrahymena thermophila,
in spite of the limited number of selectionmarkers available for this organism. To utilize pac as amaker gene
for T. thermophila, the nucleotide sequence of the pac gene was altered to accord with the most preferred
codon-usage in T. thermophila. This codon-optimized pac gene expressed in T. thermophila conferred a resistance
to transformed cells against 2000 μg/ml of puromycin dihydrochloride, whereas the growth of wild-type cells was
completely inhibited by 200 μg/ml. Furthermore, an expression cassette constructed with the codon-optimized
pac and anMTT1promoterwas effectively utilized for experiments to tag endogenous proteins of interest by fusing
the cassette into the target gene locus. These results indicate that pac can be used as a selection marker in molec-
ular studies of T. thermophila.
© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY license.1. Introduction
The ciliated protozoan Tetrahymena thermophila has been an ex-
perimental model organism for biochemistry, physiology, genetics,
molecular biology, and cell biology (Collins, 2012; Elliot, 1973).
After the macronuclear genome project was completed (Eisen et al.,
2006), it has become a powerful model cell system. T. thermophila
genes can be modiﬁed by exogenous sequences using targeting strate-
gies based on homologous recombination (Chalker, 2012 and refer-
ences cited therein). When disrupting or tagging T. thermophila genes,
neomycin-resistant gene (neo) (Gaertig et al., 1994; Kahn et al., 1993;
Shang et al., 2002) or blasticidin-resistant gene (bsr) (Brown et al.,eta-tubulin gene; chx1-1, gene
heximide sensitive; Hepes, 4-
histoneH4 gene;HHO1, histone
gene mutation expressing 6-
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region.
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. Open access under CC BY license.1999; Elde et al., 2005) expression cassettes are generally used as
exogenous selection markers. The most popular marker gene, neo,
confers resistance to paromomycin, an anti-protozoa drug. However,
paromomycin is also used as a selection drug for very popular auton-
omously replicating vectors composed of T. thermophila's mutant
rRNA gene (Chalker, 2012). Hence, the choice of drugs is limited
when multiple manipulations are attempted.
Puromycin, an analog of aminoacyl-tRNA, inhibits the incorpora-
tion of aminoacyl-tRNA into the C-terminal of a synthesizing poly-
peptide on a ribosome, resulting in premature termination of the
polypeptide chain (Nathans, 1964). Since puromycin is toxic to the
growth of various eukaryote cells including mammalian cells, a
puromycin-resistant gene (puromycin-N-acetyltransferase gene
(pac)) is commonly used as a selection marker gene in mammalian
cells (de la Luna et al., 1988; Vara et al., 1986). Because puromycin
also exhibits strong toxicity for the growth of Tetrahymena cell
(Cerroni and Zeuthen, 1962; Eckert, 1977; Frankel, 1967), it is expected
that pac could be used as a selection marker gene in Tetrahymena.
However, it has never been used in the study of Tetrahymena, due to
lack of an efﬁcient and easy to useDNAvector suitable for this organism.
In this study, we have developed a DNA vector utilizing pac as a se-
lection marker for gene manipulation in Tetrahymena. We altered
the nucleotide sequence of the pac gene to accord with the most pre-
ferred codon-usage in T. thermophila. Tetrahymena transformed with
the codon-optimized pac showed high resistance to puromycin, and
codon-optimized pac also efﬁciently worked in gene targeting experi-
ments. This study demonstrates the efﬁcacy of pac as an exogenous se-
lection marker gene for molecular studies of Tetrahymena.
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2.1. Cells, culture conditions, and induction of mating activity
T. thermophila inbred B strains, CU427.4 [chx1-1/chx1-1 (CHX1; cy-s,
VI)] and CU428.2 [mpr1-1/mpr1-1 (mp-s, VII)], were obtained from the
Tetrahymena Stock Center at Cornell University. Cells were maintained
in shallow culture medium, containing 1.5% proteose peptone (BD
Difco, Tokyo, Japan), 0.5% yeast extract (BD Difco) and 0.5% D-glucose
(Wako, Osaka, Japan), in a plastic dish at 30 °C without shaking.
For induction of mating activity, logarithmically growing cells were
harvested by centrifugation at 700 g for 1 min, washed twicewith star-
vation medium (10 mM Tris–HCl, 40 nM calcium chloride, pH 7.5) and
then incubated in the starvation medium at 2 × 105 cells/ml for
12–18 h at 30 °C. After incubation, two cell strainswith differentmating
types were mixed and further incubated for 10 h. Themating efﬁciency
of this procedure is approximately 90%. The cellswere then transformed
with exogenous DNA.2.2. Counting cells for growth curves
For growth curves, cell numbers were counted by a corpuscle densi-
ty analyzer CDA-1000 (MP JAPAN, Tokyo, Japan) with an aperture size
of 100 μm in diameter. Because this system detects and counts particles
in suspension, dead cells could not be eliminated from the counts.
Therefore, the growth curves include some dead cells.2.3. Codon optimization of pac
To construct a codon-optimized pac DNA sequence, four regions of
pac corresponding to the fragments 1–4 (see Table 1 and Fig. 2D)
were synthesized as follows: The single stranded oligo nucleotides
listed in Table 1 were chemically synthesized (Life Technologies,
Tokyo, Japan). To make a double stranded DNA of fragment 1, the
same amount of puro1/F (SacII) (a forward strand) and puro1/R (a re-
verse strand), which have a short stretch of complementary sequences
in their 3′ ends (see Fig. 2D), were mixed and then incubated at 72 °C
with PrimeSTAR reagent (Takara, Kyoto, Japan). The double stranded
DNAs of the fragments 2–4 were synthesized similarly using the for-
ward and reverse strands corresponding to each fragment listed in
Table 1. To ligate each fragment into a pBlueScript KS vector, ﬁrst the
fragments 1 and 2 were ligated into the vector as follows: Fragment 1
was digested with SacII and phosphorylated with T4 kinase (Takara);
fragment 2 was digested with XbaI; pBlueScript KS was digested with
SacII and XbaI; and fragments 1 and 2 and the vector were ligated to
generate a vector carrying fragments 1 and 2. Second, fragments 3 and
4 were ligated into the vector as follows: Fragment 3 was digested
with XbaI and phosphorylated with T4 kinase (Takara); fragment 4
was digested with ApaI; the vector carrying fragments 1 and 2 was
digested with XbaI and ApaI; and fragments 3 and 4 and the vector
were ligated to generate a vector carrying full-length codon-optimizedTable 1
Oligo nucleotides used for codon-optimization of pac.
DNA fragment Name Direction Sequence (5′→ 3′)
Fragment 1 Puro1/F(SacII) Forward GGCCGCGGATGACTGAATATAAGCCTACT
Puro1/R Reverse ATTCTTATAATTCAGTAACTCTTTCAATGT
Fragment 2 Puro2/F Forward TATTCTTAACTAGAGTTGGTTTAGATATTG
Puro2/R(XbaI) Reverse GGTCTAGAACCAGATAATTCAGCCATTCT
Fragment 3 Puro3/F(XbaI) Forward GGTCTAGATTAGCTGCTTAATAATAAATG
Puro3/R Reverse CTCTTTCAGCAGCTTCAACACCAGGTAAA
Fragment 4 Puro4/F Forward CTGGTGTTCCTGCTTTCTTAGAAACTTCTG
Puro4/R(ApaI) Reverse CCGGGCCCTCAAGCACCAGGCTTTCTAGTpac. The amino acid sequence of this codon-optimized pac protein is
same as that of the original pac protein.2.4. Construction of DNA plasmids
All DNA fragments used for plasmid construction were ampliﬁed by
PCRwith PrimeSTAR reagent. Temperatures for denaturation, annealing
and extension were 98, 55 and 72 °C, respectively. Extension time was
approximately 10 s/kb, and the reaction was repeated for 33 cycles.
To integrate the pac gene at the endogenous MTT1 gene locus (as
shown in Fig. 3A), pac ﬂanked by 5′- and 3′-ﬂanking sequences of the
MTT1 gene was constructed as follows: The codon-optimized pac gene
(opt-pac) or the original pac gene (ori-pac) was ampliﬁed from plasmid
DNA with a forward primer making a blunt end and a reverse primer
having an SpeI site. A 1963-bp 5′ﬂanking sequence of theMTT1 gene, in-
cluding theMTT1 promoter, was ampliﬁed from total genomeDNAwith
a forward primer having a SacI site and a reverse primer making a blunt
end, and then digested with SacI and phosphorylated with T4 kinase.
This 5′ ﬂanking sequence and the pac gene sequence digested with
SpeI were ligated together into a pBlueScript KS vector at the SacI and
SpeI sites. Subsequently, a 2110-bp 3′ ﬂanking sequence of the MTT1
gene, including the MTT1 3′ UTR, was ampliﬁed with a forward primer
having a SpeI site and a reverse primer having a KpnI site. After diges-
tion with restriction enzymes, the 3′ ﬂanking sequence was inserted
into the 3′ region of the pac sequence at SpeI and KpnI. Transfection of
Tetrahymena with the resulting plasmid replaces the endogenous MTT1
gene with the pac gene (Fig. 3A).
A opt-pac-expression cassette was constructed with the optimized
pac gene as follows: The codon-optimized pac gene was ampliﬁed
from a plasmid with a forward primer making blunt-end and a reverse
primer having an SpeI site, and then phosphorylatedwith T4 kinase and
digested with SpeI. This DNA was ligated to a DNA fragment of anMTT1
promoter sequence (938 bp) by blunt-end ligation, and then to a DNA
fragment of a BTU2 3′UTR sequence (306 bp) using SpeI. The expression
cassette region was inserted into pBluescript KS; it can be cut out of the
vector by EcoRI. This expression cassette with the optimized pac gene
was designated pur4: this name accords with the nomenclature of neo
cassettes for T. thermophila as the 4th generation of a codon-optimized
neomycin-resistant gene (GI:188039077) with a cadmium-inducible
MTT1 promoter (Mochizuki, 2008).
To construct the DNA plasmid used to fuse the mCherry-coding se-
quence to the 3′ end of SEH1 (designated pmCherry-SEH1), the marker
cassette region (neo4) of pmCherry-neo4 (a gift from Dr. Mochizuki)
was replacedwith the pur4 expression cassette using EcoRI sites. The re-
sultant plasmid (pmCherry-pur4) was fused with a 2066-bp 5′ ﬂanking
sequence of SEH1, which includes a large part of the SEH1 coding region
with a disrupted stop codon at SacI andNheI sites. Subsequently, a 1960-
bp sequence of a 3′ ﬂanking sequence of SEH1 starting at 613 bp from
the stop codon of SEH1 was inserted into the plasmid at the SalI and
KpnI sites (as shown in Fig. 4A).
To construct the targeting DNA plasmid used to fuse a GFP-coding
sequence to the 3′ end of HHO1 (designated pEGFP-HHO1), the markerGTTAGATTAGCTACTAGAGATGATGTTCCTAGAGCTGTTAGAACTTTAGCTGCTGCTTTCGCT
GTCTATCAGGATCAACAGTGTGTCTAGTAGCAGGATAATCAGCGAAAGCAGCAGCTAAAG
GTAAGGTTTGGGTTGCTGATGATGGTGCTGCTGTTGCTGTTTGGACTACTCCTGAATCTG
AGGACCAATTTCAGCGAAAACAGCACCAGCTTCAACAGATTCAGGAGTAGTCCAAAC
GAAGGTTTATTAGCTCCTCACAGACCTAAGGAACCTGCTTGGTTCTTAGCTACTGTTGGTG
ACAACAGCAGAACCTAAACCCTTACCTTAGTGATCAGGAGAAACACCAACAGTAGCTAAGAAC
CTCCTAGAAATTTACCTTTCTATGAAAGATTAGGTTTCACTGTTACTGCTG
CATACACCAAGTTCTAGGACCTTCAGGAACTTCAACATCAGCAGTAACAGTGAAACCTAATC
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replacedwith a bsr cassette using SmaI and SalI sites. The resultant plas-
mid (pEGFP-bsr) was fused with a 1693-bp 5′ ﬂanking sequence of
HHO1, including the HHO1 coding region, using XbaI and BamHI sites.
Subsequently, a 1486-bp 3′ ﬂanking sequence of HHO1 was inserted
into the plasmid using SalI and KpnI sites. The bsr cassette carrying a
blasticidin-resistant gene with an HHF1 promoter and the 3′ UTR of
the BTU2 gene was constructed according to Xia et al. (2000).
These DNAplasmids, whichwere to be integrated into themacronu-
clear genome, were linearized by digestion with SacI and KpnI prior to
transfection by electroporation.
cDNA of a vacuole membrane protein TTHERM_00300090 was am-
pliﬁed from cDNA library prepared from vegetative T. thermophila ac-
cording to Iwamoto et al. (2009) and inserted into the autonomously
replicating rDNA vector pVGF1 (Wiley et al., 2000) using XhoI and
ApaI sites.
All DNA plasmids were ampliﬁed in competent cells of DH5α, puri-
ﬁed with a plasmid puriﬁcation kit (Qiagen KK, Tokyo, Japan), and se-
quencing using the ABI 3100 Genetic Analyzer (Applied Biosystems,
Foster City, CA).2.5. Transfection of DNA plasmids
Mating pairs of the cells at 10 h after mixing complementary
strains were washed once with 10 mM Hepes-NaOH (pH 7.5) and
then resuspended in 10 mMHepes-NaOH (pH 7.5) at approximately
3.5 × 106 pairs/ml. The cells (mating pairs) were subjected to trans-
fection by electroporation: a mixture of 230 μl of cell suspension and
20 μl of DNA solution (containing 20 μg of pVGF1 carrying
TTHERM_00300090 cDNA or 50 μg of all other integration plasmids)
was transferred into a cuvette with a 0.2 cm gap and pulsed using a
Gene Pulser II (Bio-Rad, Hercules, CA) with 220 V, 25 μF and 200 Ω
at room temperature. The resulting cell suspension was diluted
with the culture medium and an aliquot (100 μl) was added to
each well of 96-well plates. After 18–24 h cultivation, cells (100 μl)
were treated with selection drugs: puromycin dihydrochloride
(Fermentek, Jerusalem, Israel) plus cadmium chloride at ﬁnal con-
centrations of 200 μg/ml and 1.0 μg/ml, respectively; paromomycin
sulfate (Sigma Aldrich Co., St. Louis, MO) at 120 μg/ml; or blasticidin
S (InvivoGen, San Diego, CA) at 60 μg/ml. Resistant cells usually ap-
peared 2–4 days after the drug was added.
After the selection with puromycin, diagnosing PCR was performed to
test if wild-type MTT1 gene loci were replaced with opt-pac integrated
loci.Whole genomeDNApuriﬁed frompuromycin-resistant cells was sub-
jected to PCRwith three primers (F-TACCAAACTTCTATGCATCTTGTATGTG,
R1-ATTAACAAGTCTAACACTCTTGC and R2-ACAGTAGGCTTATATTCAGTC)
and SpeedSTAR reagent (Takara). Primers F and R1 amplify a 2.6-kb
fragment from the wild-typeMTT1 gene, and primers F and R2 amplify
a 2.2-kp fragment from the pac-integrated locus. Reactionswere repeat-
ed for 33 cycles with 100 ng of genomic DNA as the template.
To select cells with resistance to all three drugs, we ﬁrst selected
cells with resistance to paromomycin and blasticidin: Cells were
co-transfected with two DNA plasmids, a pVGF1 DNA plasmid
(paromomycin resistance) carrying TTHERM_00300090 gene and a
DNA fragment carrying bsr cassette sequence (blasticidin S resis-
tance) (generated by linearization of pEGFP-HHO1 with SacI and
KpnI as described above), and cultured for 3 days in the presence
of 120 μg/ml of paromomycin sulfate and 60 μg/ml of blasticidin S.
The “double positive” cells growing under this condition were iso-
lated and transformed with a DNA fragment carrying a pur4 cassette
(puromycin resistance) (generated by linearization of pmCherry-
SEH1 with SacI and KpnI as described above). The cells were then
cultured in the presence of 400 μg/ml puromycin together with
0.5 μg/ml CdCl2 for 3 days. The cells were then treated with higher
concentrations of all three drugs (up to 300 μg/ml paromomycin,up to 500 μg/ml blasticidin S, up to 1200 μg/ml puromycin in this
case) to select for triple-drug resistant cells.
2.6. Fluorescence observation
A small aliquot of cell suspension was placed between two cover-
slips to immobilize and to ﬂatten the cells. Fluorescence images of the
cells were obtained using ﬂuorescence microscope IX-70 (Olympus,
Tokyo, Japan) and an oil-immersion objective lens UApo40 (NA = 1.35)
(Olympus) equipped on the DeltaVision microscope system (Applied
Precision, Issaquah, WA). Images were processed with denoising soft-
ware developed by Boulanger and his colleagues (Boulanger et al.,
2009).
3. Results and discussion
3.1. Tetrahymena is sensitive to puromycin
To estimate a concentration of puromycin to effectively inhibit the
cell growth of T. thermophila, we examined growth rates of cells in the
presence of various concentrations of puromycin dihydrochloride
(hereafter, puromycin) (Fig. 1A). Fiftymicrograms permilliliter of puro-
mycin reduced the growth rate by 80% in the ﬁrst 24 h, but did not
completely block cell growth; there was a gradual increase in cell num-
bers until 72 h. Initially, cell growth was completely blocked at
100 μg/ml, however, under this condition, while almost all of the
cells died in the ﬁrst 48 h, surviving cells grew rapidly after 48 h.
At 150 μg/ml, cell growth was completely inhibited for 72 h. Howev-
er, while the majority of cells died by 72 h, surviving cells grew after
72 h. (not shown). At 200 μg/ml, almost all the cells died by 48 h,
and no survivors appeared at later time points. These results suggest
that a concentration of 200 μg/ml or more is required for selecting
for transformed cells of Tetrahymena with puromycin.
Cadmium chloride (CdCl2) is often used to activate the cadmium-
inducible MTT1 promoter for expression of exogenously introduced
genes. Thus, we examinedwhether CaCl2 affects the efﬁcacy of puromy-
cin on cell growth. Growth rates were determined in the presence of
0.5 μg/ml (approximately 2.7 μM) CdCl2, a concentration high enough
to induce the promoter activity of the MTT1 gene (Fig. 1B). Growth
curves obtained in the presence of CdCl2 were similar to those obtained
in the absence of CdCl2 (compare Fig. 1A and B), suggesting that CdCl2,
at least at a concentration of 0.5 μg/ml, did not affect the growth rates
of Tetrahymena or their tolerance to puromycin.
Concentrations of puromycin sufﬁcient to inhibit cell growthofmam-
malian cells are 0.5–10 μg/ml (Lieberman and Ove, 1959; Studzinski and
Ellem, 1966; Thomas et al., 1973). These concentrations are much lower
than those required to inhibit the growth of Tetrahymena (Fig. 1). Proto-
zoa other than ciliates also exhibit low tolerance to puromycin: the path-
ogenic protozoa Plasmodium falciparum (puromycin-IC90 is 60 ng/ml;
de Koning-Ward et al., 2001), Trypanosoma cruzi (1 μg/ml inhibits infec-
tion of host cell; Piras et al., 1982) andGiardia lamblia (puromycin-IC90 is
54 μg/ml; Su et al., 2007). The tolerance to puromycin displayed by cili-
ates may be caused by their surface structure; ciliates live freely in
water and must prevent the invasion into the cell of hydrophilic mole-
cules present in the environment.
3.2. Codon-optimization of puromycin resistance gene for Tetrahymena
A puromycin-N-acetyltransferase gene (pac, GI:763525), 600-
bp in length, is derived from Streptomyces alboniger (Vara et al.,
1985, 1986). The S. alboniger pac gene is GC-rich and uses GC-rich
codons: the GC content of the pac sequence is 73.3% (Fig. 2A and
B), and the third base of each codon is biased to C or G (Fig. 2C).
In contrast, Tetrahymena prefers AT-rich codons (Eisen et al.,
2006; Wuitschick and Karrer, 1999): the third base of each codon
is biased to T in the Tetrahymena genome (Fig. 2C). As the codon-
Fig. 1.Growth curves of T. thermophila cells culturedwith puromycin. (A) The cell strain CU427 exhibiting a wild-type phenotypewas cultured inmediumwith various concentrations of
puromycin for the indicated periods. Puromycin was added to the culture at 0 h. (B) The same as panel A except that 0.5 μg/ml CdCl2 was added to the culture medium 24 h prior to the
addition of puromycin.
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2003; Novoa and Ribas de Pouplana, 2012; Redemann et al., 2011),
the translational efﬁciency of the S. alboniger pac gene might be too lowFig. 2. Sequence comparison between the original and codon-optimized puromycin N-acetyl
optimized pac sequence, only changed nucleotides are shown. Amino-acid sequence is not alte
between before and after codon-optimization. The GC contents are shown in the bottom as a
the Tetrahymena genome and the original-pac and optimized-pac proteins. The numbers in p
used for codon-optimization are mapped on the optimized-pac gene. The nucleotide sequen
procedure.for selection of drug-resistant clones when expressed in Tetrahymena.
To get higher translation efﬁciency of pac in Tetrahymena, we opti-
mized the codon-usage of pac to the most preferred one suitabletransferase (pac) genes. (A) Nucleotide and amino-acid sequences of pac. In the codon-
red after codon-optimization. (B) Comparison of the numbers of each nucleotide residue
percentage (%GC). (C) Codon-usage for selected amino acid residues, Ala, Val, and Pro, in
arentheses indicate the number of each codon used. (D) Single strand oligo nucleotides
ce of each oligo nucleotide is shown in Table 1. See Materials and methods for detailed
Fig. 3. Integration of the pacORF into theMTT1 locus in themacronuclear genome. (A) Schematic representation of the procedure. Arrows indicate the annealing positions of PCR primers
used in (C). (B) Number of wells with puromycin-resistant cells (total wells = 288). After transformation, cells were aliquoted into 288 wells (3 × 96-well plates), and the number of
positive clones was counted for codon-optimized pac and original pac. Results from two independent experiments are shown. (C) DNA fragments of the MTT1 gene locus ampliﬁed by
diagnostic PCR using primers F, R1, and R2, indicated by arrows in (A), from wild type cells (middle lane) or puromycin-resistant cells selected with puromycin up to 2000 μg/ml
(right lane). Left lane shows DNA size markers (λ phage DNA digested with HindIII). All 3 primers (F, R1, and R2) were added to the diagnostic PCR.
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of neo as a selection marker in Tetrahymena (Mochizuki, 2008). Four
oligo nucleotides covering the full length pac sequence were synthe-
sized and joined together (see Materials and methods and Fig. 2D),
resulting in modiﬁcation of one hundred sixty-eight codons out of
200 and reduction of the total GC content to 40.2% (Fig. 2B).
To test if codon-optimization effectively increases gene expression
of pac, the codon-optimized pac gene (opt-pac; GenBank Accession:
AA845356) and the original pac gene (ori-pac) were integrated into
the endogenousMTT1 loci in themacronuclear genome of T. thermophila
by homologous recombination (Fig. 3A):MTT1 is a gene coding for me-
tallothionein (TTHERM_00241640, GI:118383466). The frequency of
appearance of puromycin-resistant clones was measured for cells cul-
tured in the presence of 200 μg/ml of puromycin: CdCl2 was also
added to the culture medium to a ﬁnal concentration of 0.5 μg/ml to ac-
tivate the MTT1 promoter. Puromycin-resistant clones emerged in
130–148 out of 288 wells for opt-pac whereas puromycin-resistant
clones emerged in only 12–17 wells for ori-pac (Fig. 3B), indicating
that codon-optimization is highly effective in raising puromycin toler-
ance in Tetrahymena cells.
Puromycin-resistant clones with opt-pacwere continuously selected
by increased concentrations of puromycin up to 2000 μg/ml in the cul-
ture medium, with 0.5–1.0 μg/ml CdCl2. The macronuclear genome in
T. thermophila is polyploid, consists of approximately 45-multiplied
copies; therefore, we determined how much macronuclear genomic
DNA was replaced with opt-pac in the puromycin-resistant clones. For
this purpose, genomic DNA was isolated from the cells resistant to
2000 μg/ml puromycin, and MTT1 loci were ampliﬁed by PCR. In the
puromycin-resistant cells, a DNA fragment corresponding to opt-pac
was detected, but the fragment corresponding to the wild-type MTT1
was not (Fig. 3C), suggesting that most of macronuclearMTT1 gene loci
were replaced by opt-pac by phenotypic assortment (Sonneborn,
1974). Puromycin-resistant clones sometimes grew with up to
2200 μg/ml puromycin, although in the most cases they could not.
These results suggest that the maximum concentration of puromycinappropriate for selection with opt-pac is around 2000 μg/ml when driv-
en by theMTT1 promoter activated with 0.5–1.0 μg/ml CdCl2.3.3. Application of the opt-pac-expression cassette (pur4)
To utilize the opt-pac gene as a selection marker for gene
targeting experiments, we constructed a DNA plasmid carrying the
opt-pac-expression cassette, pur4, as described in Materials and
methods. pur4 is 1.9 kb in length and composed of anMTT1 promoter
(Shang et al., 2002), the opt-pac gene (this study), and a BTU2 termi-
nator (Gaertig et al., 1994). The pur4 cassette was used to construct
a DNA plasmid for tagging a gene of interest with an mCherry
gene (mCherry-pur4) (Fig. 4A). The mCherry-pur4 construct was
integrated into the 3′ end of the macronuclear SEH1 gene
(TTHERM_00954180, GI:289576326), which encodes the 42-kDa
nucleoporin Seh1, a component of the nuclear pore complex
(Iwamoto et al., 2009). After cultivation under gradually increasing
concentrations of puromycin up to 600 μg/ml, Seh1-mCherry ﬂuo-
rescence was located at the NPCs (data not shown; see Fig. 4B,
right panel, for Seh1-mCherry expressed with two other compo-
nents). This result indicates that pur4 can be used as a selection
marker for gene manipulation in T. thermophila.
Similar to the results described above with opt-pac, cells carrying
pur4 could grow in the presence of puromycin at concentrations of up
to 2000 μg/ml puromycin, but not at puromycin concentrations greater
than 2000 μg/ml.We also examined howmany copies of the SEH1 gene
were replaced with the tagged gene. As for opt-pac and theMTT1 locus,
the whole genome was puriﬁed from cells exhibiting resistance to
2000 μg/ml puromycin and occupation of the SEH1 gene loci by the
tagged genewas analyzed by PCR.Wild-type SEH1 gene lociwere barely
detectable (data not shown), suggesting that in the presence of
2000 μg/ml of puromycin most of the SEH1 gene loci were replaced
with the tagged gene. This result is consistent with the result from inte-
gration of opt-pac into theMTT1 locus shown in Fig. 3.
Fig. 4. Simultaneous expression of three target proteins independently-tagged with ﬂuorescent proteins. (A) Schematic representation of the gene tagging of the nucleoporin Seh1 gene
(SEH1) with an mCherry gene using the pur4 cassette. (B) Fluorescence images of a single Tetrahymena cell simultaneously expressing three different target protein tagged with GFP or
mCherry: histone H1-GFP (asterisk in left panel), GFP-TTHERM_00300090 (bubble-like structures located in the cytoplasm in the left panel), and Seh1-mCherry (see the nuclear rim of
the macronucleus indicated by the asterisk in the right panel). The cells expressing a SEH1 gene fused with an mCherry gene were selected with approximately 1200 μg/ml puromycin
in the presence of 0.5 μg/ml CdCl2. The cells expressing macronuclear histone H1 gene (HHO1) fused with a GFP gene were selected with approximately 500 μg/ml blasticidin S. The
cells expressing GFP-TTHERM_00300090 cloned into a pVGF1 vector were selected with approximately 300 μg/ml paromomycin. The asterisk indicates themacronucleus, and the dotted
line represents the outline of a cell. Scale bar represents 20 μm. In the left panel, H1-GFP and GFP-TTHERM_00300090 were localized in the macronucleus and on the membranes of nu-
merous food vacuoles dispersed in the cytoplasm, respectively. In the right panel, Seh1-mCherry was observed in the macronuclear envelope. The micronucleus was invisible because it
positioned behind the macronucleus in this cell. The numerous collateral ﬂuorescent structures observed with the excitation channel for mCherry are the contents of food vacuoles. They
are probably surplus Seh1-mCherry being digested by autophagocytosis.
254 M. Iwamoto et al. / Gene 534 (2014) 249–255Next, we examined the use of pur4 simultaneously with bsr
(blasticidin S resistance) and rDNA-based pVGF1 (paromomycin resis-
tance). SEH1 in cells in which HHO1 (histone H1, GI:161794) had been
tagged with GFP using the bsr cassette and in which GFP-TTHERM_
00300090 (a vacuole membrane protein, GI:118382760) had been
introduced using the autonomously replicating vector pVGF1 were
tagged with mCherry using pur4 as described above. These three
ﬂuorescence-labeled proteins were expressed simultaneously in a
single cell (Fig. 4B). This result indicates that the puromycin-resistant
gene, pur4, can act as an additional marker and can be used together
with paromomycin and/or blasticidin S resistant genes.
In the presence of paromomycin and blasticidin S resistant genes,
however, 150–200 μg/ml of puromycin was insufﬁcient for the ﬁrst
screening for puromycin-resistant cells; all wells of the plate contained
survivor cells at these concentrations. This unexpected high-resistance
to puromycin in multiple drug resistant cells was probably due to
cross-resistance of other drug resistant genes to puromycin. Conse-
quently, higher puromycin concentrations, 400 μg/ml, were required
for the ﬁrst selection of the cells shown in Fig. 4B. It should be noted
that addition of very high concentrations of puromycin (over
2500 μg/ml) to the culture medium containing yeast extracts made
the medium cloudy (data not shown). This may be caused by unknown
reactions of puromycinwith some substances originated from the yeast
extracts. To avoid this problem, when very high concentrations of puro-
mycin are required, the use of proteose peptone medium, instead of
medium containing yeast extract, is recommended: Cells can grow
with a normal doubling time in proteose peptonemedium supplement-
ed with Fe ion (Orias et al., 1999).
For selection of puromycin-resistant cells transformed with pur4, the
effective concentrations of puromycin range from 200 μg/ml (the con-
centration for the initial selection) to 2000 μg/ml (for replacement of
most macronuclear gene copies). This range is narrower than that used
for selection of paromomycin-resistant cells transformed with neo4,
which ranges from 100 μg/ml to approximately 80,000 μg/ml of
paromomycin. Puromycin seems to bemore effective thanparomomycin,and thus may shorten the selection period required for replacement
of macronuclear gene loci. In addition to this potential advantage,
the use of puromycin has other advantages: Blasticidin, unlike puro-
mycin, is mutagenic, so cells selected with blasticidin will have an
unknown number of non-lethal mutations. Puromycin is also much
less deleterious than blasticidin S to accidently exposed humans.
These facts make puromycin a valuable additional selection marker
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